BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

576 related articles for article (PubMed ID: 15545514)

  • 21. Endogenous p53 protects vascular smooth muscle cells from apoptosis and reduces atherosclerosis in ApoE knockout mice.
    Mercer J; Figg N; Stoneman V; Braganza D; Bennett MR
    Circ Res; 2005 Apr; 96(6):667-74. PubMed ID: 15746445
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Alcohol inhibits the progression as well as the initiation of atherosclerotic lesions in C57Bl/6 hyperlipidemic mice.
    Emeson EE; Manaves V; Emeson BS; Chen L; Jovanovic I
    Alcohol Clin Exp Res; 2000 Sep; 24(9):1456-66. PubMed ID: 11003214
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of diet-induced atheroma formation in transgenic mice expressing apolipoprotein E in the arterial wall.
    Shimano H; Ohsuga J; Shimada M; Namba Y; Gotoda T; Harada K; Katsuki M; Yazaki Y; Yamada N
    J Clin Invest; 1995 Feb; 95(2):469-76. PubMed ID: 7860728
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ticlopidine attenuates progression of atherosclerosis in apolipoprotein E and low density lipoprotein receptor double knockout mice.
    Jawien J; Csanyi G; Gajda M; Mateuszuk L; Lomnicka M; Korbut R; Chlopicki S
    Eur J Pharmacol; 2007 Feb; 556(1-3):129-35. PubMed ID: 17174298
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition of diet-induced atherosclerosis and endothelial dysfunction in apolipoprotein E/angiotensin II type 1A receptor double-knockout mice.
    Wassmann S; Czech T; van Eickels M; Fleming I; Böhm M; Nickenig G
    Circulation; 2004 Nov; 110(19):3062-7. PubMed ID: 15277329
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Apolipoprotein E promotes the regression of atherosclerosis independently of lowering plasma cholesterol levels.
    Raffai RL; Loeb SM; Weisgraber KH
    Arterioscler Thromb Vasc Biol; 2005 Feb; 25(2):436-41. PubMed ID: 15591220
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hepatic expression of apolipoprotein E inhibits progression of atherosclerosis without reducing cholesterol levels in LDL receptor-deficient mice.
    Tsukamoto K; Tangirala RK; Chun S; Usher D; Puré E; Rader DJ
    Mol Ther; 2000 Feb; 1(2):189-94. PubMed ID: 10933930
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increase in serum amyloid a evoked by dietary cholesterol is associated with increased atherosclerosis in mice.
    Lewis KE; Kirk EA; McDonald TO; Wang S; Wight TN; O'Brien KD; Chait A
    Circulation; 2004 Aug; 110(5):540-5. PubMed ID: 15277327
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Oral flavonoid supplementation attenuates atherosclerosis development in apolipoprotein E-deficient mice.
    Hishikawa K; Nakaki T; Fujita T
    Arterioscler Thromb Vasc Biol; 2005 Feb; 25(2):442-6. PubMed ID: 15499038
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hydrogen sulfide regulates vascular endoplasmic reticulum stress in apolipoprotein E knockout mice.
    Chen ZF; Zhao B; Tang XY; Li W; Zhu LL; Tang CS; DU JB; Jin HF
    Chin Med J (Engl); 2011 Nov; 124(21):3460-7. PubMed ID: 22340159
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interleukin-1 receptor signaling mediates atherosclerosis associated with bacterial exposure and/or a high-fat diet in a murine apolipoprotein E heterozygote model: pharmacotherapeutic implications.
    Chi H; Messas E; Levine RA; Graves DT; Amar S
    Circulation; 2004 Sep; 110(12):1678-85. PubMed ID: 15353494
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High-density lipoproteins retard the progression of atherosclerosis and favorably remodel lesions without suppressing indices of inflammation or oxidation.
    Choudhury RP; Rong JX; Trogan E; Elmalem VI; Dansky HM; Breslow JL; Witztum JL; Fallon JT; Fisher EA
    Arterioscler Thromb Vasc Biol; 2004 Oct; 24(10):1904-9. PubMed ID: 15319266
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lack of interleukin-1 receptor antagonist modulates plaque composition in apolipoprotein E-deficient mice.
    Isoda K; Sawada S; Ishigami N; Matsuki T; Miyazaki K; Kusuhara M; Iwakura Y; Ohsuzu F
    Arterioscler Thromb Vasc Biol; 2004 Jun; 24(6):1068-73. PubMed ID: 15059807
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Uremia accelerates both atherosclerosis and arterial calcification in apolipoprotein E knockout mice.
    Massy ZA; Ivanovski O; Nguyen-Khoa T; Angulo J; Szumilak D; Mothu N; Phan O; Daudon M; Lacour B; Drüeke TB; Muntzel MS
    J Am Soc Nephrol; 2005 Jan; 16(1):109-16. PubMed ID: 15563564
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Oral D-4F causes formation of pre-beta high-density lipoprotein and improves high-density lipoprotein-mediated cholesterol efflux and reverse cholesterol transport from macrophages in apolipoprotein E-null mice.
    Navab M; Anantharamaiah GM; Reddy ST; Hama S; Hough G; Grijalva VR; Wagner AC; Frank JS; Datta G; Garber D; Fogelman AM
    Circulation; 2004 Jun; 109(25):3215-20. PubMed ID: 15197147
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of low dose atorvastatin versus diet-induced cholesterol lowering on atherosclerotic lesion progression and inflammation in apolipoprotein E*3-Leiden transgenic mice.
    Verschuren L; Kleemann R; Offerman EH; Szalai AJ; Emeis SJ; Princen HM; Kooistra T
    Arterioscler Thromb Vasc Biol; 2005 Jan; 25(1):161-7. PubMed ID: 15514207
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antiatherogenic effects of oleanolic acid in apolipoprotein E knockout mice.
    Buus NH; Hansson NC; Rodriguez-Rodriguez R; Stankevicius E; Andersen MR; Simonsen U
    Eur J Pharmacol; 2011 Nov; 670(2-3):519-26. PubMed ID: 21958874
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Deficiency of Niemann-Pick C1 Like 1 prevents atherosclerosis in ApoE-/- mice.
    Davis HR; Hoos LM; Tetzloff G; Maguire M; Zhu LJ; Graziano MP; Altmann SW
    Arterioscler Thromb Vasc Biol; 2007 Apr; 27(4):841-9. PubMed ID: 17218600
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lack of complement factor C3, but not factor B, increases hyperlipidemia and atherosclerosis in apolipoprotein E-/- low-density lipoprotein receptor-/- mice.
    Persson L; Borén J; Robertson AK; Wallenius V; Hansson GK; Pekna M
    Arterioscler Thromb Vasc Biol; 2004 Jun; 24(6):1062-7. PubMed ID: 15059809
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Retardation of atherosclerosis by overexpression of catalase or both Cu/Zn-superoxide dismutase and catalase in mice lacking apolipoprotein E.
    Yang H; Roberts LJ; Shi MJ; Zhou LC; Ballard BR; Richardson A; Guo ZM
    Circ Res; 2004 Nov; 95(11):1075-81. PubMed ID: 15528470
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.